United States · Biopharma startup

CAMP4 Therapeutics

CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.

Funding reportedLast round: Series B

BiopharmaCambridge, United States

What company datasets say CAMP4 Therapeutics raised

Funding, as reported

Reported in all$190Min dollars
Rounds4
Last roundSeries B
Last round dateJul 2022
Investors listed8
SEC Form D$195M sold, 4 filings, last Jun 2022

Founders and team

From CAMP4 Therapeutics's own website and the SEC filings it signed: 10 on the team.

  • Josh Mandel-BrehmPresident & Chief Executive Officer
  • Caleb MooreChief Business Operations Officer
  • Kelly GoldChief Financial Officer
  • Michelle GatesChief People Officer
  • Andy SchwabDirector
  • Michael MacLeanDirector
  • Alfica SehgalExecutive Officeri
  • Ann BarbierExecutive Officeri
  • David BumcrotExecutive Officeri
  • Steve HoltzmanDirector

On the board, as filediAmir NashatAndrew J. SchwabJames J. BoylanJorge CondeMichael HigginsPaula RaganRavi I. ThadhaniRichard YoungShaan I. Gandhi

Biopharma in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put CAMP4 Therapeutics in front of investors. Or tell us what we have wrong.

List your startupSend a correction